Hyundai Meditech Co., Ltd. (CEO Song Mi-hee) announced that it will participate in the 3th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 23’, which will be held at COEX, Seoul from March 26rd (Thursday) to 38th (Sunday).
Hyundai Meditech is a manufacturing and export company in the medical and beauty industries, building a reputation at home and abroad with more than 20 years of business experience. For many years, Hyundai Meditech has been laying the foundation by participating in conferences and exhibitions around the world to become a leader in the global aesthetic medical device market. According to the official, the company has received certifications from countries around the world, including ISO13485, CE, KGMP, KFDA, ANMET, INVIMA, ANVISA, and TGA, and is currently supplying products to long-term customers in over 40 countries around the world. In addition, its excellence in quality was recognized by receiving MDSAP certification in 2022.
In this exhibition, polydioxanone suture will be exhibited. This is a product composed of a sterilized needle, a general-purpose catheter cannula, and absorbable suture made of polydioxanone, and is a product used in the human body for treatment purposes, not for the purpose of administering drugs.
The filler that will be introduced together is an injection solution made by cross-linking colorless and transparent viscous sodium hyaluronate provided in the form of a prefilled syringe. The company explained that the product is a biomaterial for tissue repair that is used to temporarily improve facial wrinkles in adults through physical restoration by injecting it under the skin. In addition, ‘ERUA:JAE’ and ‘HDNA Cream’ will also be introduced.
A Hyundai Meditech official said, “We spared no effort in research and investment to create excellent products with purely domestic technology. In addition, we aimed to produce products that customers could trust and use with confidence by equipping them with state-of-the-art automation facilities. “Through these efforts, we have received various certifications and proven our excellence,” he said. “Customer satisfaction is high enough to lead to repeat purchases.” “We decided to participate in this exhibition to set a new standard by introducing these medical devices to more customers,” he explained.
He continued, “We are exporting products with medical device approval to various overseas countries, and in particular, we are mainly exporting polydioxanone suture products to Latin America. It is growing at over 20% every year and will achieve sales of over 2022 billion won in 100. In particular, based on the MDSAP certification received last year, we are in the process of licensing in 15 countries in the Americas, including the United States, Mexico, and Canada,” he said, adding, “We will not be complacent and will continue to conduct research to ensure that people can purchase our products with confidence.” .
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.